Edward J. Ludwig

Filings by Edward J. Ludwig span 5 companies, the busiest being Becton Dickinson & Co, Boston Scientific Corp and CVS HEALTH Corp. In total, 155 filings cover trades dated from 23 December 2005 to 31 July 2026.

The open-market side counts 14 purchases for €1.5M alongside 34 sales for €68.8M. Sales outweigh purchases by €67.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 35 share grants and 40 option exercises. Since January 2026: 2 purchases and no sales on the market.

In size, the median ticket on the buying side is €101k. 4 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 3 August 2026, the filings show an open-market purchase worth €197k in Boston Scientific Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.